Regulatory haplotypes in ARG1 are associated with altered bronchodilator response

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 4, 2011, Pages 449-454

  Duan, Qing Ling ^a   Gaume, Brigitte R ^b   Hawkins, Gregory A ^c   Himes, Blanca E ^a,d,e,f   Bleecker, Eugene R ^c   Klanderman, Barbara ^a   Irvin, Charles G ^g   Peters, Stephen P ^c   Meyers, Deborah A ^c   Hanrahan, John P ^h   Lima, John J ⁱ   Litonjua, Augusto A ^a   Tantisira, Kelan G ^a   Liggett, Stephen B ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f LABORATORY FOR MOLECULAR MEDICINE   (United States)

^g UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^h CareFusion   (United States)

ⁱ NEMOURS CHILDREN S CLINIC   (United States)

Author keywords

2 agonist; Asthma; Pharmacogenetics

Indexed keywords

ARGINASE 1; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; LUCIFERASE;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; HAPLOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; LOCUS CERULEUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUTEROL; ARGINASE; ASTHMA; BRONCHODILATOR AGENTS; CHILD; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 79951825578     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201005-0758OC     Document Type: Article

References (34)

1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy 2004;59:469-478. (Pubitemid 38580764)
2. Drazen JM, Silverman EK, Lee TH. Heterogeneity of therapeutic responses in asthma. Br Med Bull 2000;56:1054-1070. (Pubitemid 32417168)
3. Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Pineiro A, Wei LX, Seidenberg BC, Reiss TF. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized, controlled trial. Montelukast/beclomethasone study group. Ann Intern Med 1999;130:487-495. (Pubitemid 29135801)
4. Raby BA, Weiss ST. Beta2-adrenergic receptor genetics. Curr Opin Mol Ther 2001;3:554-566.
5. Litonjua AA, Lasky-Su J, Schneiter K, Tantisira KG, Lazarus R, Klanderman B, Lima JJ, Irvin CG, Peters SP, Hanrahan JP, et al. Arg1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med 2008;178:688-694.
6. Salam MT, Islam T, Gauderman WJ, Gilliland FD. Roles of arginase variants, atopy, and ozone in childhood asthma. J Allergy Clin Immunol 2009;123:596-602, 602 e591-598.
7. Li H, Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Estela Del Rio-Navarro B, Kistner EO, Gjessing HK, Lara-Sanchez Idel C, Chiu GY, London SJ. Genetic polymorphisms in arginase I and II and childhood asthma and atopy. J Allergy Clin Immunol 2006;117:119-126. (Pubitemid 43019225)
8. Kochansky L, Kossman S, Rogala E, Dworniki J. Arginase activity in sputum of patients with bronchial asthma. Pneum Pol 1980;48:329-332.
9. Meurs H, Maarsingh H, Zaagsma J. Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol Sci 2003;24:450-455. (Pubitemid 37088169)
10. Lara A, Khatri SB, Wang Z, Comhair SA, Xu W, Dweik RA, Bodine M, Levison BS, Hammel J, Bleecker E, et al. Alterations of the arginine metabolome in asthma. Am J Respir Crit Care Med 2008;178:673-681.
11. Yang M, Rangasamy D, Matthaei KI, Frew AJ, Zimmmermann N, Mahalingam S, Webb DC, Tremethick DJ, Thompson PJ, Hogan SP, et al. Inhibition of arginase I activity by MA interference attenuates IL-13-induced airways hyperresponsiveness. J Immunol 2006;177: 5595-5603. (Pubitemid 44527634)
12. Duan QL, Gaume BR, Hawkins GA, Bleecker ER, Himes BE, Litonjua AA, Liggett SB, Tantisira KG, Weiss ST. Regulatory haplotypes in arg1 are associated with bronchodilator response. New Orleans, LA: American Thoracic Society; 2010.
13. Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's severe asthma research program. J Allergy Clin Immunol 2007;119:405-413. (Pubitemid 46210080)
14. Lester LA, Rich SS, Blumenthal MN, Togias A, Murphy S, Malveaux F, Miller ME, Dunston GM, Solway J, Wolf RL, et al. Ethnic differences in asthma and associated phenotypes: collaborative study on the genetics of asthma. J Allergy Clin Immunol 2001;108:357-362. (Pubitemid 32881055)
15. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144: 1202-1218.
16. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26: 948-968. (Pubitemid 41632054)
17. Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ, Wise RA. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 2007;356:2027-2039. (Pubitemid 46789893)
18. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. Plink: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575. (Pubitemid 47330214)
19. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-434. (Pubitemid 34112296)
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188. (Pubitemid 17189972)
21. Panebra A, Schwarb MR, Glinka CB, Liggett SB. Heterogeneity of transcription factor expression and regulation in human airway epithelial and smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2007;293:L453-L462. (Pubitemid 47205026)
22. Meurs H, McKay S, Maarsingh H, Hamer MA, Macic L, Molendijk N, Zaagsma J. Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br J Pharmacol 2002;136:391-398. (Pubitemid 34620520)
23. Maarsingh H, Leusink J, Bos IS, Zaagsma J, Meurs H. Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma. Respir Res 2006;7:6.
24. Maarsingh H, Pera T, Meurs H. Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch Pharmacol 2008;378:171-184.
25. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 1997;94:6954-6958. (Pubitemid 27281972)
26. Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol 2001;64:365-391. (Pubitemid 32244139)
27. Akiho H, Blennerhassett P, Deng Y, Collins SM. Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2002; 282:G226-G232. (Pubitemid 34651678)
28. Mehta S, Drazen JM, Lilly CM. Endogenous nitric oxide and allergic bronchial hyperresponsiveness in guinea pigs. Am J Physiol 1997;273: L656-L662. (Pubitemid 27423934)
29. McGraw DW, Elwing JM, Fogel KM, Wang WC, Glinka CB, Mihlbachler KA, Rothenberg ME, Liggett SB. Crosstalk between GI and GQ/GS pathways in airway smooth muscle regulates bronchial contractility and relaxation. J Clin Invest 2007;117:1391-1398. (Pubitemid 46718427)
30. McGraw DW, Fogel KM, Kong S, Litonjua AA, Kranias EG, Aronow BJ, Liggett SB. Transcriptional response to persistent beta2-adrenergic receptor signaling reveals regulation of phospholamban, which alters airway contractility. Physiol Genomics 2006;27:171-177. (Pubitemid 46702030)
31. McGraw DW, Almoosa KF, Paul RJ, Kobilka BK, Liggett SB. Antithetic regulation by beta-adrenergic receptors of GQ receptor signaling via phospholipase C underlies the airway beta-agonist paradox. J Clin Invest 2003;112:619-626. (Pubitemid 38056346)
32. Maarsingh H, Zuidhof AB, Bos IS, van Duin M, Boucher JL, Zaagsma J, Meurs H. Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation. Am J Respir Crit Care Med 2008;178:565-573.
33. Ckless K, van der Vliet A, Janssen-Heininger Y. Oxidative-nitrosative stress and post-translational protein modifications: implications to lung structure-function relations. Arginase modulates NF-kappab activity via a nitric oxide-dependent mechanism. Am J Respir Cell Mol Biol 2007;36:645-653. (Pubitemid 46871418)
34. Niese KA, Collier AR, Hajek AR, Cederbaum SD, O'Brien WE, Wills-Karp M, Rothenberg ME, Zimmermann N. Bone marrow cell derived arginase I is the major source of allergen-induced lung arginase but is not required for airway hyperresponsiveness, remodeling and lung inflammatory responses in mice. BMC Immunol 2009;10:33.